Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft
PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has officially opened its newly expanded Clinical Center of Excellence in Rockford, IL.
Rockford City Council Director of Community and Economic Development, Karl Franzen commented at the launch: “Established and growing companies such as PCI play a critical role in our economic development, including creating employment opportunities for local people. We can all be proud that PCI’s presence here reflects the significance of the manufacturing sector in the Midwest, and of the work it does in providing vital medicines for people around the world. I am delighted to be a part of this event and wish PCI every success in the future.”
Construction began in November 2018 and was completed this month, delivering 30,000 sq ft of additional space with increased flexibility and scalability for primary and secondary packaging, labeling, and 2-8°C Cold Chain storage. The premiere featured key community and PCI leadership, who welcomed the opening as a major advancement for customers and ultimately patients in clinical trials. The expansion also includes a new customer reception area as well as increased office space to support PCI staff growth.
PCI’s Chief Operating Officer Brad Payne added: “The Rockford Clinical facility expansion delivers significant new capacity across our core offerings of primary and secondary packaging as well as Cold Chain storage and distribution. This investment is one of many PCI is making across our global clinical supply chain in strategic locations in the US, UK, Europe, and Australia to ensure we can meet our clients’ global needs by packaging and delivering life-saving therapeutic products to patients worldwide.”
Commenting on the growth and future of PCI’s Clinical business, PCI’s Brian Keesee, Vice President and General Manager, Global Operations and Supply for Clinical Services, stated: “We support specialized medicines with special handling requirements for Clinical trials all around the world, at different stages, and the ability to respond quickly to our clients’ needs is always of paramount importance to successful trial outcomes. Our new suites in Rockford allow us to provide faster turnaround times and increased flexibility, ensuring we continue to deliver on our number one commitment to our clients: to provide the industry’s leading customer experience.”
PCI’s ongoing investment in state-of-the-art facilities and technology demonstrates its long-standing commitment to providing both current and future customers with the highest standards of excellence in Clinical Services. Its Rockford site is the largest of PCI’s eight locations across the US, EU and Asia Pacific regions – supporting Clinical Trials in more than 100 countries around the world.
To find out more about PCI, please visit here.
About PCI Pharma Services
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.